Humana 2009 Annual Report Download - page 132

Download and view the complete annual report

Please find page 132 of the 2009 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 140

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140

Humana Inc.
SCHEDULE I—PARENT COMPANY FINANCIAL INFORMATION
CONDENSED STATEMENTS OF CASH FLOWS
For the year ended December 31,
2009 2008 2007
(in thousands)
Net cash provided by operating activities ...................... $911,090 $ 547,813 $ 682,374
Cash flows from investing activities:
Acquisitions ........................................... (5,867) (341,288) (548,251)
Purchases of investment securities .......................... (597,858) (7,528) (25,147)
Proceeds from sale of investment securities .................. 2,309 28,868 100,001
Maturities of investment securities ......................... 278,443 2,489 15,213
Purchases of property and equipment, net .................... (142,931) (195,517) (139,962)
Capital contributions to operating subsidiaries ................ (132,257) (467,750) (307,340)
Change in securities lending collateral ...................... — 400,292 (400,211)
Net cash used in investing activities .................... (598,161) (580,434) (1,305,697)
Cash flows from financing activities:
Borrowings under credit agreement ......................... — 1,175,000 1,685,000
Repayments under credit agreement ........................ (250,000) (1,725,000) (1,335,000)
Proceeds from issuance of senior notes ...................... — 749,247 —
Debt issue costs ........................................ — (6,696) —
Proceeds from swap termination ........................... — 93,008 —
Repayment of notes issued to operating subsidiaries ............ — — (9,450)
Change in book overdraft ................................. 34,264 (27,720) 876
Change in securities lending payable ........................ — (400,292) 400,211
Common stock repurchases ............................... (22,841) (106,070) (27,412)
Tax benefit from stock-based compensation .................. 5,339 9,912 37,443
Proceeds from stock option exercises and other ............... 17,040 10,965 61,643
Net cash (used in) provided by financing activities ......... (216,198) (227,646) 813,311
Increase (decrease) in cash and cash equivalents ................... 96,731 (260,267) 189,988
Cash and cash equivalents at beginning of year .................... 249,061 509,328 319,340
Cash and cash equivalents at end of year ......................... $345,792 $ 249,061 $ 509,328
See accompanying notes to the parent company financial statements.
122